Search results
In initial victory for Argentine President Milei, Senate gives overall approval to key reform bills
Associated Press· 14 hours agoSenators voted 37 to 36 late Wednesday to give their overall approval to the overhaul bill after 11...
Maryland PSC rejects Exelon utility’s $213.6M multiyear rate plan
Utility Dive via Yahoo Finance· 1 day agoPepco’s plan, however, was opposed by the Maryland Office of People’s Counsel, which argued that...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 16 hours agoEarlier in the year, one analyst called results from the cancer vaccine study "transformational."...
In initial win for Argentine President Milei, senators approve his key bills after violent protests
KIRO 7 Seattle-Tacoma· 6 hours agoSenators voted 37 to 36 late Wednesday to give their overall approval to the overhaul bill after 11...
How to get a credit-builder loan
Bankrate via AOL· 17 hours agoYou can get a free copy of your credit report from Experian, TransUnion and Equifax...Compare your options It’s always best to shop around before you...
Chase Sapphire Preferred review: A standout travel card with impressive perks
Yahoo Personal Finance· 17 hours agoAll opinions belong solely to the author(s) and are not those of any other entity. The details on...
New Netflix movie debuts with 100% Rotten Tomatoes rating
Digital Spy· 2 days agoUltraman: Rising, the new film from Netflix, has landed a perfect 100% approval rating on Rotten...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 17 hours agoLorbrena-treated patients had an 81% reduced risk of death. In other news, Pfizer beat first-quarter...
Jasper Therapeutics Announces Executive Changes and Stockholder Approvals By Investing.com
Investing.com· 21 hours agoJasper Therapeutics, Inc. (NASDAQ:JSPR), a biopharmaceutical company focused on biological products,...
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Investor's Business Daily· 14 hours agoRegeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug,...
